Analyst Conference Summaries

Biotechnology Investor Aids

Cidera Therapeutics

conference date: February 25, 2021 press release only.

Coverage of Cidera has not yet begun, though I started buying the stock in March 2021.

Cidera Therapeutics Q1 2021 Press Release      
May 13, 2021      

Cidera Therapeutics (CTDX) is a clinical-stage biotechnology company specializing in therapies for viral and fungal infections.

Cidera Therapeutics web site



More Analyst Conference Pages:


Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2021 William P. Meyers